Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Clinical Study on Pre-operative Intervention With Products During Aesthetic Medicine
Sponsor: Botanee Group Co., Ltd.
Summary
This clinical trial aims to evaluate whether a 14-day pre-operative application of the test product (containing MLYAAT-1002®, a proprietary anti-aging complex) can mitigate skin discomfort during Fotona 4D laser therapy (Frac3 and Piano modes) by comparing clinical evaluation, skin attributes measurement and subject self-assessment.
Official title: Clinical Study on Pre-operative Intervention With Products to Mitigate Skin Discomfort During Aesthetic Medicine
Key Details
Gender
FEMALE
Age Range
35 Years - 60 Years
Study Type
INTERVENTIONAL
Enrollment
33
Start Date
2025-03-25
Completion Date
2025-06-01
Last Updated
2025-04-01
Healthy Volunteers
Yes
Interventions
14-day daily pre-operative application of the formulations containing MLYAAT-1002® before Fotona4D treatment
All enrolled subjects will complete a 14-day washout period followed by a 14-day run-in phase prior to Fotona 4D® laser treatment. During the initial washout phase, participants will exclusively use basic skincare products: sunscreen, cleansing foam, and moisturizing emulsion. Then the subjects will apply the formulations containing MLYAAT-1002® of the active comparator to randomly assigned split-face (the treatment side) for the subsequent 14-day period. Following completion of the product application regimen, all participants will undergo a single session of Fotona 4D laser therapy.
14-day daily pre-operative application of the formulations without MLYAAT-1002® before Fotona4D treatment
All enrolled subjects will complete a 14-day washout period followed by a 14-day run-in phase prior to Fotona 4D® laser treatment. During the initial washout phase, participants will exclusively use basic skincare products: sunscreen, cleansing foam, and moisturizing emulsion. Then the subjects will apply the formulations without MLYAAT-1002® of the placebo comparator to randomly assigned split-face (the control side) for the subsequent 14-day period. Following completion of the product application regimen, all participants will undergo a single session of Fotona 4D laser therapy.